FrancophonIA/ELRC3.0 huggingface dataset:
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. PROIZVAJALEC(PROIZVAJALCI) BIOLOŠKE (BIOLOŠKIH) UČINKOVINE ( UČINKOVIN) IN PROIZVAJALEC (PROIZVAJALCI) ZDRAVILA, ODGOVOREN (ODGOVORNI) ZA SPROŠČANJE SERIJ
English: Disodium hydrogen phosphate dodecahydrate Sodium chloride
Slovenian: FARMACEVTSKI PODATKI 6.1 Seznam pomožnih snovi aluminijev hidroksid saponin tiomersal kalijev klorid kalijev dihidrogenfosfat natrijev hidrogenfosfat dodekahidrat natrijev klorid voda za injekcije
English: Fertility:
Slovenian: Laktacija:
English: *(Cycling value (Ct) ≥ 36 by a validated RT-PCR method, indicating no presence of viral genome).
Slovenian: *(Ciklična vrednost (Ct) ≥ 36 pri validirani metodi RT-PCR, kar kaže, da virusni genom ni prisoten) Nastop imunosti: 21 dni po osnovnem programu cepljenja.
English: Name and address of the manufacturer of the biological active substance
Slovenian: Ime in naslov proizvajalca (proizvajalcev) biološke (bioloških) učinkovine (učinkovin)
English: A transient increase in rectal temperature, not exceeding 0.6 °C, may occur during the 24 hours following administration of a two-fold overdose.
Slovenian: Do 24 ur po dajanju dvojnega odmerka se lahko pojavi prehodno povišanje rektalne temperature, ki ne presega 0,6 °C.
English: Active immunisation of sheep from 1.5 months of age for the prevention* of viraemia caused by Bluetongue virus, serotypes 1 and 8.
Slovenian: INDIKACIJA(E) Aktivna imunizacija ovac, starejših od 1,5 meseca, za preprečitev* viremije, ki jo povzroča virus bolezni modrikastega jezika, serotipa 1 in 8.
English: Pack sizes:
Slovenian: Pakiranja:
English: The entire content of the bottle should be used immediately after broaching and during the same procedure.
Slovenian: Takoj po odpiranju porabite naenkrat celotno vsebino stekleničke.
English: 1 bottle of 120 doses (240 ml).
Slovenian: 1 viala s 120 odmerki (240 ml).
English: 1 bottle of 10 doses (20 ml).
Slovenian: 1 viala z 10 odmerki (20 ml).
English: Aluminium hydroxide Saponin
Slovenian: aluminijev hidroksid, saponin, tiomersal.
English: SPAIN
Slovenian: Girona ŠPANIJA
English: Inactivated Bluetongue virus, serotype 1, strain BTV-1/ALG2006/01 E1 RP* ≥ 1 Inactivated Bluetongue virus, serotype 8, strain BTV-8/BEL2006/02 RP* ≥ 1
Slovenian: inaktiviran virus bolezni modrikastega jezika, serotip 1, sev BTV-1/ALG2006/01 E1 RP* ≥ 1 inaktiviran virus bolezni modrikastega jezika, serotip 8, sev BTV-8/BEL2006/02 RP* ≥ 1
English: 1 bottle of 50 doses (100 ml).
Slovenian: 1 viala s 50 odmerki (100 ml).
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE Vial label 100 ml and 240 ml
Slovenian: PODATKI NA STIČNI OZ. PRIMARNI OVOJNINI Nalepka na viali 100 ml in 240 ml
English: Pack of 1 bottle of 10 doses (20 ml).
Slovenian: Velikost pakiranja: Pakiranje z 1 vialo z 10 odmerki (20 ml).
English: MARKETING AUTHORISATION NUMBER(S) EU/2/11/120/001-003
Slovenian: ŠTEVILKA(E) DOVOLJENJ(A) ZA PROMET EU/2/11/120/001-003
English: 240 ml
Slovenian: 100 ml 240 ml
English: MARKETING AUTHORISATION NUMBER(S) EU/2/11/120/001
Slovenian: ŠTEVILKA(E) DOVOLJENJ(A) ZA PROMET EU/2/11/120/001
English: 4.9 Amounts to be administered and administration route
Slovenian: 4.9 Odmerjanje in pot uporabe Subkutana uporaba.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/11/120/002
Slovenian: ŠTEVILKA(E) DOVOLJENJ(A) ZA PROMET EU/2/11/120/002
English: Pharmacotherapeutic group: Inactivated viral vaccines for sheep, Bluetongue virus.
Slovenian: Farmakoterapevtska skupina: Inaktivirana virusna cepiva - virus bolezni modrikastega jezika.Oznaka ATC vet: QI04AA02
English: Inactivated Bluetongue virus, serotype 1, strain BTV-1/ALG2006/01 E1 Inactivated Bluetongue virus, serotype 8, strain BTV-8/BEL2006/02
Slovenian: V odmerku 2 ml: inaktiviran virus bolezni modrikastega jezika, serotip 1, sev BTV-1/ALG2006/01 E1 inaktiviran virus bolezni modrikastega jezika, serotip 8, sev BTV-8/BEL2006/02
English: Special precautions for use in animals: Only use in healthy animals.
Slovenian: Posebni previdnostni ukrepi za uporabo pri živalih:
English: QUANTITY OF THE ACTIVE SUBSTANCE(S) Per dose of 2 ml:
Slovenian: Vsak odmerek (2 ml) vsebuje:
English: Date of first authorisation: 17 October 2003 Date of latest renewal: 17 October 2008
Slovenian: Datum prve odobritve: 17. oktober 2003 Datum zadnjega podaljšanja: 17. oktober 2008
English: Therefore, do not take Stalevo and iron supplements at the same time.
Slovenian: Zato ne jemljite zdravila Stalevo in železovih dodatkov sočasno.
English: Experience with Stalevo in patients under 18 years is limited.
Slovenian: Izkušnje z zdravilom Stalevo pri bolnikih, starih manj kot 18 let, so omejene.
English: Therefore, the use of Stalevo in children or adolescents is not recommended.
Slovenian: Zato se uporaba zdravila Stalevo pri otrocih ali mladostnikih ne priporoča.
English: You should be aware that Stalevo may make these reactions worse.
Slovenian: Zavedati se morate, da lahko zdravilo Stalevo te reakcije še poslabša.
English: Your doctor may take some regular laboratory tests during a long term treatment with Stalevo.
Slovenian: Zdravnik lahko izvede nekaj rednih laboratorijskih preiskav med dolgoročnim zdravljenjem z zdravilom Stalevo.
English: Stalevo with food and drink
Slovenian: Zdravilo Stalevo skupaj s hrano in pijačo
English: Paediatric population: The safety and efficacy of Stalevo in children aged below 18 years have not been established.
Slovenian: Pediatrična populacija: Varnost in učinkovitost zdravila Stalevo pri otrocih starih do 18 let nista bili dokazani.
English: What Stalevo is and what it is used for
Slovenian: Kaj je zdravilo Stalevo in za kaj ga uporabljamo
English: The starting dose of Stalevo should provide either the same amount of levodopa or slightly (5-10%) more.
Slovenian: Začetni odmerek zdravila Stalevo naj zagotavlja enako ali nekoliko (5-10 %) večjo količino levodope.
English: Stalevo should not be used during pregnancy unless the benefits for the mother outweigh the possible risks to the foetus.
Slovenian: Zdravila Stalevo ne smete uporabljati pri nosečnicah, razen če koristi za mater ne odtehtajo morebitnega tveganja za plod.
English: However, caution should be exercised when these medicinal products are used concomitantly with Stalevo (see sections 4.3 and 4.4).
Slovenian: Vseeno pa je potrebna previdnost, kadar se ta zdravila uporabljajo sočasno z zdravilom Stalevo (glejte poglavji 4.3 in 4.4).
English: For some patients, Stalevo may not be well absorbed if it is taken with, or shortly after eating protein-rich food (such as meats, fish, dairy products, seeds and nuts).
Slovenian: Pri nekaterih bolnikih se zdravilo Stalevo ne absorbira tako dobro, če ga jemljejo med obrokom ali kmalu po obroku proteinsko bogate hrane (npr. meso, ribe, mlečni izdelki, semena in oreški).
English: - All patients treated with Stalevo should be monitored carefully for the development of mental changes, depression with suicidal tendencies, and other serious antisocial behaviour.
Slovenian: - Vse bolnike, ki se zdravijo z zdravilom Stalevo, je treba skrbno spremljati, če bi prišlo do psihičnih sprememb, depresije s samomorilnimi nagnjenji ter drugih resnih oblik antisocialnega vedenja.
English: What you need to know before you take Stalevo
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Stalevo
English: However, in an interaction study with healthy volunteers, entacapone did not change the plasma levels of S-warfarin, while the AUC for R-warfarin increased on average by 18% [CI90 1126%].
Slovenian: Vendar pa v raziskavi interakcij pri zdravih prostovoljcih entakapon ni povzročil spremembe plazemskih koncentracij S-varfarina, med tem, ko so se vrednosti AUC R-varfarina povečale v povprečju za 18 % [CI90 11-26 %].
English: Other medicines and Stalevo
Slovenian: Druga zdravila in zdravilo Stalevo
English: Daily ON time with and without entacapone was recorded in home-diaries by patients.
Slovenian: Dnevni interval učinkovanja zdravila z ali brez entakapona so bolniki beležili v domači dnevnik.
English: If you must undergo surgery, please tell your doctor that you are using Stalevo.
Slovenian: Če morate na operacijo, povejte svojemu zdravniku, da jemljete zdravilo Stalevo.
English: Detailed information on this medicinal product is available on the website of European Medicines Agency http://www.ema.europa.eu
Slovenian: Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu
English: Do not take Stalevo if you are taking certain medicines for treating depression (combinations of selective MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).
Slovenian: Ne uporabljajte zdravila Stalevo, če jemljete nekatera zdravila za zdravljenje depresije (kombinacija selektivnih zaviralcev MAO-A in MAO-B ali neselektivnih zaviralcev MAO).
English: In the pharmacokinetic studies with Stalevo the bioavailability of levodopa is higher in women than in men, primarily due to the difference in body weight, while there is no gender difference with carbidopa and entacapone.
Slovenian: V raziskavah farmakokinetike zdravila Stalevo je biološka uporabnost levodope pri ženskah večja kot pri moških predvsem zaradi razlike v telesni masi, medtem ko pri karbidopi in entakaponu razlike med spoloma ni bilo.
English: Stalevo may lower your blood pressure, which may make you feel light-headed or dizzy.
Slovenian: Zdravilo Stalevo lahko zniža vaš krvni tlak, zaradi česar se boste počutili vrtoglavi in omotični.
English: If you have accidentally taken more Stalevo tablets than you should, talk to your doctor or pharmacist immediately.
Slovenian: Če ste po naključju vzeli več tablet zdravila Stalevo, kot bi smeli, se nemudoma posvetujte s svojim zdravnikom ali farmacevtom.
English: Stalevo may have a major influence on the ability to drive and use machines.
Slovenian: Zdravilo Stalevo ima pomemben vpliv na sposobnost vožnje in upravljanja strojev.
English: Therefore Stalevo should be given cautiously to patients who are taking other medicinal products which may cause orthostatic hypotension.
Slovenian: Zato je potrebna previdnost pri dajanju zdravila Stalevo bolnikom, ki jemljejo druga zdravila, ki lahko povzročajo ortostatsko hipotenzijo.
English: - Stalevo contains sucrose, and therefore patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Slovenian: - Zdravilo Stalevo vsebuje saharozo, zato bolniki z redkimi prirojenimi motnjami, kot so intoleranca za fruktozo, malabsorpcija glukoze-galaktoze ali pomanjkanje saharaze-izomaltaze, ne smejo jemati tega zdravila.
English: It may therefore be necessary, particularly in patients with dyskinesia, to reduce levodopa dose by 10-30% within the first days to first weeks after initiating Stalevo treatment.
Slovenian: Zato bo morda potrebno v prvih dneh oziroma prvih tednih po uvedbi zdravljenja z zdravilom Stalevo, zlasti pri bolnikih z diskinezijo zmanjšati odmerek levodope za 10-30 %.
English: Stalevo is used for the treatment of Parkinson's disease.
Slovenian: Zdravilo Stalevo se uporablja za zdravljenje Parkinsonove bolezni.
English: Pyridoxine, however, is not effective in reversing the actions of Stalevo.
Slovenian: Vendar pa piridoksin ni učinkovit kot protisredstvo za delovanje zdravila Stalevo.
English: - If general anaesthesia is required, therapy with Stalevo may be continued for as long as the patient is permitted to take fluids and medicinal products by mouth.
Slovenian: - Če je potrebna splošna anestezija, se lahko terapija z zdravilom Stalevo nadaljuje vse dokler sme bolnik jemati tekočine in zdravila peroralno.
English: If you take more Stalevo than you should
Slovenian: Če ste vzeli večji odmerek zdravila Stalevo, kot bi smeli
English: How to transfer patients not currently treated with entacapone to Stalevo
Slovenian: Kako preusmeriti bolnike, ki trenutno ne prejemajo entakapona, na zdravilo Stalevo
English: Therefore, Stalevo and iron preparations should be taken at least 2-3 hours apart (see section 4.8).
Slovenian: Zato je treba pri jemanju zdravila Stalevo in železovih pripravkov upoštevati najmanj 2-3 urni razmak med obema zdraviloma (glejte poglavje 4.8).
English: Do not stop taking Stalevo unless your doctor tells you to.
Slovenian: Ne prenehajte z jemanjem zdravila Stalevo razen po navodilih zdravnika.
English: Other forms of interactions: Since levodopa competes with certain amino acids, the absorption of Stalevo may be impaired in some patients on high protein diet.
Slovenian: Druge oblike interakcij: Ker levodopa tekmuje (kompetitira) z nekaterimi aminokislinami, je lahko pri nekaterih bolnikih, ki uživajo visoko proteinsko dieto, absorpcija zdravila Stalevo motena.
English: If you stop taking Stalevo
Slovenian: Če ste prenehali jemati zdravilo Stalevo
English: At the initiation, Stalevo should be adjusted to correspond as closely as possible to the total daily dose of levodopa currently used.
Slovenian: Ob uvedbi zdravljenja je treba zdravilo Stalevo prilagoditi tako, da kar najbolj odgovarja skupnemu do sedaj uporabljanemu dnevnemu odmerku levodope.
English: - Stalevo is not recommended for the treatment of drug-induced extrapyramidal reactions.
Slovenian: - Zdravilo Stalevo se ne priporoča za zdravljenje ekstrapiramidnih reakcij, ki jih povzročajo zdravila.
English: Patients taking these medicinal products with Stalevo should be carefully observed for loss of therapeutic response.
Slovenian: Bolnike, ki jemljejo ta zdravila poleg zdravila Stalevo, je treba skrbno spremljati zaradi morebitnega zmanjšanja terapevtskega odgovora.
English: When used with Stalevo, the daily dose of selegiline should not exceed 10 mg.
Slovenian: Ob sočasni uporabi z zdravilom Stalevo skupni dnevni odmerek selegilina ne sme presegati 10 mg.
English: Stalevo may increase the effects and side effects of certain medicines.
Slovenian: Zdravilo Stalevo lahko poveča učinke in neželene učinke določenih zdravil.
English: Stalevo contains three active substances (levodopa, carbidopa and entacapone) in one film-coated tablet.
Slovenian: Zdravilo Stalevo vsebuje tri učinkovine (levodopo, kabidopo in entakapon) v eni filmsko obloženi tableti.
English: Tell your doctor if you or your family/carer notices you are developing addiction-like symptoms leading to craving for large doses of Stalevo and other medicines used to treat Parkinson's disease.
Slovenian: Obvestite zdravnika, če vi ali kdo od družinskih članov/negovalec opazi(te), da se pri vas razvijajo simptomi, podobni odvisnosti, ki vodijo do potrebe po velikih odmerkih zdravila Stalevo in drugih zdravil za zdravljenje Parkinsonove bolezni.
English: Patients should be instructed to take only one Stalevo tablet per dose administration.
Slovenian: Bolnikom je treba razložiti, da naj ob vsakem odmerku vzamejo samo eno tableto zdravila Stalevo.
English: Other antiparkinsonian medicinal products: To date there has been no indication of interactions that would preclude concurrent use of standard antiparkinsonian medicinal products with Stalevo therapy.
Slovenian: Drugi antiparkinsoniki: Do sedaj niso znane nobene interakcije, ki bi omejevale sočasno uporabo standardnih antiparkinsonikov in zdravila Stalevo.
English: - Patients with chronic wide-angle glaucoma may be treated with Stalevo with caution, provided the intra-ocular pressure is well controlled and the patient is monitored carefully for changes in intra-ocular pressure.
Slovenian: - Bolniki s kroničnim glavkomom odprtega zakotja se ob primerni previdnosti lahko zdravijo z zdravilom Stalevo, pod pogojem, da je intraokularni tlak dobro obvladovan in da bolnika skrbno spremljamo, če bi se pojavile spremembe v intraokularnem tlaku.
English: If you forget to take Stalevo
Slovenian: Če ste pozabili vzeti zdravilo Stalevo
English: If this happens, you should not drive or use any tools or machines (see also section 'Driving and using machines') - notice that uncontrolled movements begin or get worse after you started to take Stalevo.
Slovenian: Če se vam to zgodi, ne vozite in ne upravljajte strojev (glejte tudi poglavje »Vpliv na sposobnost upravljanja vozil in strojev«); - potem, ko ste začeli jemati zdravilo Stalevo, pojavijo nekontrolirani gibi, ali se ti pojavi poslabšajo.
English: However, a direct switch from levodopa/DDC inhibitor to Stalevo is not recommended for patients who have dyskinesias or whose daily levodopa dose is above 800 mg.
Slovenian: Neposreden prehod z levodope/zaviralcev DDK na zdravilo Stalevo pa ni priporočljiv pri bolnikih z diskinezijo ali pri tistih z dnevnim odmerkom levodope nad 800 mg.
English: The possibility that the patient has taken other active substances in addition to Stalevo should be taken into consideration.
Slovenian: Upoštevati je treba možnost, da je bolnik vzel poleg zdravila Stalevo še druga zdravila.
English: Due to entacapone's affinity to cytochrome P450 2C9 in vitro (see section 5.2), Stalevo may potentially interfere with active substances whose metabolism is dependent on this isoenzyme, such as S-warfarin.
Slovenian: Ker ima entakapon afiniteto za citokrom P450 2C9 in vitro (glejte poglavje 5.2), lahko zdravilo Stalevo potencialno vpliva na delovanje učinkovin katerih presnova je odvisna od tega izoencima, kot je to S-varfarin.
English: If other levodopa products are used concomitantly with a Stalevo tablet, the maximum dose recommendations should be followed.
Slovenian: Če se sočasno s tabletami zdravila Stalevo uporabljajo druga zdravila z levodopo, je treba upoštevati priporočila o največjem dovoljenem odmerjanju.
English: Patients being treated with Stalevo and presenting with somnolence and/or sudden sleep onset episodes must be instructed to refrain from driving or engaging in activities where impaired alertness may put themselves or others at risk of serious injury or death (e.g. operating machines) until such recurrent episodes have resolved (see section 4.4).
Slovenian: Bolnikom, ki se zdravijo z zdravilom Stalevo in navajajo pojav zaspanosti in nenadnega spanca, je treba odsvetovati da vozijo ali se udejstvujejo v dejavnostih, pri katerih lahko zaradi zmanjšane pozornosti sebe ali druge izpostavljajo nevarnosti resne poškodbe ali smrti (npr. upravljanje strojev), vse dokler te epizode ne minejo (glejte poglavje 4.4).
English: What Stalevo is and what it is used for What you need to know before you take Stalevo How to take Stalevo
Slovenian: Kaj je zdravilo Stalevo in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Stalevo Kako jemati zdravilo Stalevo Možni neželeni učinki
English: If you suddenly stop taking Stalevo and other antiparkinsonian medicines it may result in unwanted side effects.
Slovenian: Če boste nenadno prenehali jemati tablete zdravila Stalevo in druge antiparkinsonike, lahko doživite neželene učinke.
English: The most frequently reported adverse reactions with Stalevo are dyskinesias occurring in approximately 19% of patients; gastrointestinal symptoms including nausea and diarrhoea occurring in approximately 15% and 12% of patients, respectively; muscle, musculoskeletal and connective tissue pain occurring in approximately 12% of patients; and harmless reddish-brown discolouration of urine (chromaturia) occurring in approximately 10% of patients.
Slovenian: Najpogostejši neželeni učinki, o katerih so poročali pri zdravilu Stalevo, so diskinezija, ki se pojavi pri približno 19 % bolnikov; gastrointestinalni simptomi vključno z navzeo in drisko, ki se pojavijo pri 15 % oz. 12 % bolnikov, bolečina mišic, mišično-skeletna bolečina in bolečina vezivnega tkiva, ki se pojavi pri približno 12 % bolnikov; neškodljivo rdečkastorjavkasto obarvanje urina (kromaturija), ki se pojavi pri približno 10 % bolnikov.
English: The evidence of the therapeutic effects of Stalevo is based on two phase III double-blind studies, in which 376 Parkinson's disease patients with end-of-dose motor fluctuations received either entacapone or placebo with each levodopa/DDC inhibitor dose.
Slovenian: Dokazi o terapevtskih učinkih zdravila Stalevo temeljijo na dveh dvojno slepih raziskavah III. faze, v katerih je 376 bolnikov s Parkinsonovo boleznijo in motoričnimi fluktuacijami na koncu odmernega obdobja ob vsakem odmerku levodope/zaviralca DDK prejemalo bodisi entakapon ali placebo.
English: 5 How to store Stalevo Contents of the pack and other information
Slovenian: 5 Shranjevanje zdravila Stalevo Vsebina pakiranja in dodatne informacije
English: Because the effects of Stalevo tablets are equivalent with entacapone 200 mg tablet administered concomitantly with the commercially available standard release carbidopa/levodopa preparations in corresponding doses these results are applicable to describe the effects of Stalevo as well.
Slovenian: Ker so učinki tablet zdravila Stalevo enaki kot pri tabletah entakapona 200 mg, uporabljenih sočasno z zdravili karbidope/levodope s standardnim sproščanjem v odgovarjajočih odmerkih, so ti rezultati uporabni tudi za prikaz učinkov zdravila Stalevo.
English: For adults and elderly: - Your doctor will tell you exactly how many tablets of Stalevo to take each day.
Slovenian: Za odrasle in starejše: - Vaš zdravnik vam bo povedal, koliko tablet zdravila Stalevo morate vzeti vsak dan. - Tableta ni namenjena za deljenje ali drobljenje na manjše koščke.
English: Stalevo is not recommended to be used for treatment of extrapyramidal symptoms (e.g. involuntary movements, shaking, muscle rigidity and muscle contractions) caused by other medicines.
Slovenian: Zdravilo Stalevo se ne priporoča za zdravljenje ekstrapiramidnih simptomov (npr. nehotnih gibov, tremorja, otrdelosti mišic in mišičnih kontrakcij), ki jih povzročajo druga zdravila.
English: The effects of Stalevo may be weakened by certain medicines.
Slovenian: Nekatera zdravila lahko oslabijo učinek zdravila Stalevo.
English: c. When initiating Stalevo in patients currently treated with entacapone and levodopa/benserazide in a standard release formulation, the dosing of levodopa/benserazide should be discontinued in the previous night, and Stalevo should be started in the next morning.
Slovenian: c. Ko se zdravljenje z zdravilom Stalevo uvaja pri bolnikih, ki trenutno prejemajo entakapon in levodopo/benzerazid s standardnim sproščanjem, je treba odmerjanje levodope/benzerazida eno noč ukiniti in naslednje jutro začeti dajati zdravilo Stalevo.
English: - Stalevo may induce orthostatic hypotension.
Slovenian: - Zdravilo Stalevo lahko povzroči ortostatsko hipotenzijo.
English: Elderly: No dose adjustment of Stalevo is required for elderly.
Slovenian: Starejši: Prilagajanje odmerka pri starejših ni potrebno.
English: Not known (cannot be estimated from the available data) Craving for large doses of Stalevo in excess of that required to control motor symptoms, known as dopamine dysregulation syndrome.
Slovenian: Neznana pogostnost (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti) Potreba po visokih odmerkih zdravila Stalevo, ki presegajo odmerek, ustrezen za obvladovanje motoričnih simptomov, ki se imenuje sindrom motene regulacije dopamina.
English: In such patients it is advisable to introduce entacapone treatment as a separate treatment (entacapone tablets) and adjust the levodopa dose if necessary, before switching to Stalevo.
Slovenian: Pri takih bolnikih je priporočljivo pred prehodom na zdravilo Stalevo uvesti zdravljenje z entakaponom kot samostojnim zdravljenjem (entakapon v obliki tablet), odmerek levodope pa po potrebi prilagoditi.
English: Management of acute overdose with Stalevo therapy is similar to acute overdose with levodopa.
Slovenian: Ukrepi pri akutnem prevelikem odmerjanju zdravila Stalevo so podobni kot pri akutnem prevelikem odmerjanju levodope.